Biotech Cyclacel Pharmaceuticals Reviews 2020 Achievements and Announces Key Business Objectives for 2021 January 11, 2021
Biotech Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference January 11, 2021
Biotech Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with Parkinson’s Disease January 11, 2021
Biotech Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn Bioventures, BVF Partners, L.P. and Maven Investment Partners January 11, 2021
Biotech Affimed Announces Euro25 Million Debt Financing Agreement with Silicon Valley Bank January 11, 2021
Biotech ASLAN Pharmaceuticals Opens Expansion Cohort in ASLAN004 Atopic Dermatitis Clinical Trial January 11, 2021
Biotech ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – FBIO January 9, 2021
Biotech Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – MTSC, PRVL, RLH, CGIX January 9, 2021
Search
bio stock
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 9, 2021
January 9, 2021
